ArticleCell death & disease2021

Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.

Iga K Mieczkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.